Imported from EML workbook.
Formulations: - Parenteral > General injections > IV: 500 µg per mL in 1 mL ampoule (as sulfate); 500 µg per mL in 5 mL ampoule (as sulfate) Respiratory > Inhalation > solution: 100 µg per actuation in pressurized metered dose inhaler (as sulfate); 2.5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers; 5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers; 5 mg per mL in multi-dose bottle (as sulfate) for use in nebulizers Indications: - Chronic obstructive pulmonary disease - Asthma Source: EML workbook import
Indications: - Chronic obstructive pulmonary disease - Asthma Source: EML workbook import
Formulations: - Respiratory > Inhalation > powder: 18 µg in capsule Respiratory > Inhalation > solution: 1.25 µg per actuation in soft mist inhaler; 2.5 µg per actuation in soft mist inhaler Indications: - Chronic obstructive pulmonary disease Source: EML workbook import
Indications: - Chronic obstructive pulmonary disease Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.